Yusuf et al (67) reported that AML cells that were deficient in ALDH3A2 had altered biosynthetic pathways, exhibited increased oxidative damage and had an altered cellular lipid composition. This evidence concerns the gene ALDH3A2 and acute myeloid leukemia.